Sr. Communications Manager
Society for Clinical Research Sites
FOR IMMEDIATE RELEASE
Ellicott City, MD, August 27, 2019 – Today the Society for Clinical Research Sites (SCRS) announced the top 5 sponsor and CRO finalists for the 2019 SCRS Eagle Award™, selected from companies nominated by SCRS members. The SCRS Eagle Award honors one sponsor and one CRO that exemplify a site-focused approach to clinical trial management. The winning sponsor and CRO will be announced October 14th at the Global Site Solutions Summit in Hollywood, FL.
Congratulations to the top 5 2019 sponsor Eagle Award finalists: AstraZeneca, Lilly, Novo Nordisk, Pfizer, and Roche.
Congratulations to the top 5 2019 CRO Eagle Award finalists: Covance, ICON plc, IQVIA, PRA Health Sciences, and Syneos Health.
“We are excited to see the SCRS member site community so eager to nominate the sponsors and CROs that consistently demonstrate commitment to site relationships and sustainability,” said SCRS president Casey Orvin. “Congratulations to the 2019 Eagle Award finalists! We look forward to honoring each of you in Hollywood at the Global Site Solutions Summit and celebrating the winning sponsor and CRO during the Eagle Award Gala.”
Voting is now open to all clinical research site professionals, regardless of their membership status with SCRS. The opportunity to vote closes September 6th.
Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Our Voice. Our Community. Your Success. Join the community. Visit MySCRS.org.